by CalmUmberBison1mo agoUSDG pair0xa2df41…da70eb
Opus Genetics (Nasdaq: IRD) — gene therapy for inherited retinal disease. Stock +32% on Sept 9, 2026 on positive Phase 1/2 OPGx-BEST1 data.
Reading trades.